TGFB1 and neoplasm: In contrast, the overexpression of receptors involved in the transmigration of Tregs and other immunosuppressive cells on the surface of tumor endothelium, along with upregulation of inhibitory proteins such as TGFβ, FasL, and PD-L1, create conditions preventing the effective anti-tumor immune response40–42.